ClinicalTrials.gg
Status unknownNCT01211041Updated Apr 25, 2011

The Relationship Between Morphology and Virulent Genes of Candida Albicans and Clinical Aspects, Surveillance of Fungemia

An observational study in Candidemia Prognostic Factor and Mycobiological Analysis., sponsored by Taipei Medical University WanFang Hospital. Status unknown at 1 site in Taiwan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2011-04-25.

Sponsored by Taipei Medical University WanFang Hospital · Observational

The sponsor has not verified this record recently (last verified Apr 2011), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

Candida albicans is the most common and important clinical fungal pathogen. Our previous surveillance disclosed that fluconazole could induce different morphological changes in clinical strains. Our current study on C. albicans causing candiuria disclosed that renal insufficiency , diabetes mellitus, respiratory failure and uremia were risk factors of treatment failure. However, we also found results of E-test drug susceptible test could not predict outcome. Hence, retrospective analysis of 31 months period, cases that had C. albicans inducing candidemia were reviewed and 60 cases were enrolled for morphological study and potential virulent gene analysis.

This study is designed to clarity the clinical meaning of morphological form and virulent genes on candidemia. To do this study is probably helpful for treatment of candidiasis.

02

Conditions studied

  • Candidemia Prognostic Factor and Mycobiological Analysis.

Browse trials for

Keywords

  • Candida albicans, fungemia , prognostic factor
03

In context

Fungemia

32 studies on the registry are indexed under Fungemia; 3 are open to participants now.

This study's planned enrollment of 100 is below the median of 740 across 12 observational studies indexed under Fungemia.

Browse Fungemia studies →

Lead sponsor

Taipei Medical University WanFang Hospital is the lead sponsor of 201 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

case with candidemia of Candida albicans and candida caused the disease .

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 2007 to 2010 medical records
  • Cases with candidemmia of Candida albicans with available clinical information in medical records for analysis.
  • Cases with candidemmia of Candida albicans which clinical isolates were preserved.

Exclusion criteria

Exclusion Criteria:

  • Cases were not hospitalized for treatment and data were not available for analysis.
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
100 participants (estimated)
06

Study locations

1 of 1 sites recruiting
  • Taipei Medical University - WanFang Hospital
    Taipei, Taiwan
    Recruiting
07

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jul 2010 and a completion of Jul 2011. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 28, 2010
First posted
Sep 29, 2010
Start
Jul 2010
CompletionEst.
Jul 2011
Last update
Apr 25, 2011
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 25, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT01211041
First posted
Sep 29, 2010
Start date
Jul 2010
Completion
Jul 2011 (estimated)
Last update
Apr 25, 2011

Study contacts

Tsong-Yih Ou
Contact
93023@wanfang.gov.tw
886-2-29307930 ext. 1760
Tsong-Yih Ou
principal investigator · Taipei Medical University WanFang Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion